EGFR and breast cancer: PI4K2A is a key enzyme for the synthesis of phosphatidylinositol 4-phosphate with multiple cell signaling functions36, which is critical for epidermal growth factor receptor degradation37, transferrin receptor recycling38, autophagy-lysosome fusion39 and prognosis of breast cancer patients40.